Literature DB >> 31794058

COL1-related overlap disorder: A novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers-Danlos syndrome overlap.

Silvia Morlino1, Lucia Micale2, Marco Ritelli3, Marianne Rohrbach4, Nicoletta Zoppi3, Anthony Vandersteen5, Sara Mackay5, Emanuele Agolini6, Dario Cocciadiferro6, Erina Sasaki7, Annalisa Madeo8, Alessandro Ferraris1, Willie Reardon7, Maja Di Rocco8, Antonio Novelli6, Paola Grammatico1, Fransiska Malfait9, Tommaso Mazza10, Alan Hakim11, Cecilia Giunta12, Marina Colombi3, Marco Castori2.   

Abstract

The 2017 classification of Ehlers-Danlos syndromes (EDS) identifies three types associated with causative variants in COL1A1/COL1A2 and distinct from osteogenesis imperfecta (OI). Previously, patients have been described with variable features of both disorders, and causative variants in COL1A1/COL1A2; but this phenotype has not been included in the current classification. Here, we expand and re-define this OI/EDS overlap as a missing EDS type. Twenty-one individuals from 13 families were reported, in whom COL1A1/COL1A2 variants were found after a suspicion of EDS. None of them could be classified as affected by OI or by any of the three recognized EDS variants associated with COL1A1/COL1A2. This phenotype is dominated by EDS-related features. OI-related features were limited to mildly reduced bone mass, occasional fractures and short stature. Eight COL1A1/COL1A2 variants were novel and five recurrent with a predominance of glycine substitutions affecting residues within the procollagen N-proteinase cleavage site of α1(I) and α2(I) procollagens. Selected variants were investigated by biochemical, ultrastructural and immunofluorescence studies. The pattern of observed changes in the dermis and in vitro for selected variants was more typical of EDS rather than OI. Our findings indicate the existence of a wider recognizable spectrum associated with COL1A1/COL1A2.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COL1A1; COL1A2; Ehlers-Danlos syndrome; joint hypermobility; osteogenesis imperfecta

Year:  2019        PMID: 31794058     DOI: 10.1111/cge.13683

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

Review 1.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

Review 2.  Ehlers-Danlos syndrome: what the radiologist needs to know.

Authors:  Michael P George; Natasha E Shur; Jeannette M Peréz-Rosselló
Journal:  Pediatr Radiol       Date:  2021-05-17

3.  Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.

Authors:  Lucia Micale; Carmela Fusco; Marco Castori
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Osteogenesis Imperfecta/Ehlers-Danlos Overlap Syndrome and Neuroblastoma-Case Report and Review of Literature.

Authors:  Letteria Anna Morabito; Anna Elsa Maria Allegri; Anna Paola Capra; Mario Capasso; Valeria Capra; Alberto Garaventa; Mohamad Maghnie; Silvana Briuglia; Malgorzata Gabriela Wasniewska
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.141

5.  Next-Generation Sequencing of Connective Tissue Genes in Patients with Classical Ehlers-Danlos Syndrome.

Authors:  Anna Junkiert-Czarnecka; Maria Pilarska-Deltow; Aneta Bąk; Marta Heise; Anna Latos-Bieleńska; Jacek Zaremba; Alicja Bartoszewska-Kubiak; Olga Haus
Journal:  Curr Issues Mol Biol       Date:  2022-03-25       Impact factor: 2.976

6.  Identification of the novel COL5A1 c.3369_3431dup, p.(Glu1124_Gly1144dup) variant in a patient with incomplete classical Ehlers-Danlos syndrome: The importance of phenotype-guided genetic testing.

Authors:  Marco Ritelli; Valeria Cinquina; Marina Venturini; Marina Colombi
Journal:  Mol Genet Genomic Med       Date:  2020-07-28       Impact factor: 2.183

7.  Prepubertal Periodontitis in a Patient with Combined Classical and Periodontal Ehlers-Danlos Syndrome.

Authors:  Friedrich Stock; Marcel Hanisch; Sarah Lechner; Saskia Biskup; Axel Bohring; Johannes Zschocke; Ines Kapferer-Seebacher
Journal:  Biomolecules       Date:  2021-01-24

Review 8.  Collagen Fibrillogenesis in the Mitral Valve: It's a Matter of Compliance.

Authors:  Richard L Goodwin; Arash Kheradvar; Russell A Norris; Robert L Price; Jay D Potts
Journal:  J Cardiovasc Dev Dis       Date:  2021-08-20

9.  Clinical and molecular features of patients with COL1-related disorders: Implications for the wider spectrum and the risk of vascular complications.

Authors:  Ryojun Takeda; Tomomi Yamaguchi; Shujiro Hayashi; Shinichirou Sano; Hiroshi Kawame; Sachiko Kanki; Takeshi Taketani; Hidekane Yoshimura; Yukio Nakamura; Tomoki Kosho
Journal:  Am J Med Genet A       Date:  2022-07-13       Impact factor: 2.578

10.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.